sons are inexperienced and untrained technicians, the infrequency of test performance, the use of unstandardized equipment, and the lack of appropriate standards. It behooves all clinical laboratory directors to re-examine and standardize their procedures and use the recommendations of the Cystic Fibrosis Foundation. Physicians should be made aware of the current situation and send their patients only to laboratories that perform the test reli- The purpose of this report is to document our experience during two years, comparing sweat-test results for patients referred to us because of the diagnosis of possible cystic fibrosis (CF). Some patients with known cystic fibrosis, also referred because of uncommon complications or for therapeutic suggestions, had been diagnosed and treated in other Cystic Fibrosis Centers. Most of the patients coming to me were referred by pediatricians who had considered the diagnosis of cystic fibrosis and had sweat tests performed in their local institutions. During 1976 and 1977 a total of 143 patients were referred to us who had already had sweat tests.
Procedure
The sweat test performed in our laboratory since 1960 is the standard quantitative pilocarpine iontophoresis test (1) . The detailed procedure has been described elsewhere (2 sweat glands on the forearm are stimulated with pilocarpine and a 2.5-mA current. This step, which requires 5 mm, has not caused a burn or a serious local reaction in more than 24 000 tests. Next, sweat is collected for 25 mm onto weighed gauze pads, previously tested for contamination. Evaporation of sweat is prevented. Any condensate on the plastic seal is included in the weighed gauze pad. At least 50 mg of sweat is required for the analysis, but much larger amounts usually are produced. The error in the chemical assay is inversely related to the volume of sweat. When a small sample volume is anticipated, sweat collected from both the left and right forearms is combined, although this theoretically is undesirable because a low sweat rate may yield lower electrolyte values. Sodium and potassium are determined by flame photometry, chloride by the Schales and Schales method (3).
These analyses were done in duplicate in about half the patients in this study when the patients were first seen, in addition to a chloride plate test (4) . In many cases the clinical history, including family history, was obtained and a physical examination made. Additional tests, done only if deemed to be useful, included chest roentgenograms, sweat testing of siblings, stool-trypsin tests, sputum or throat cultures, serum protein analysis, allergy studies, and follow-up visits. Several patients were seen on subsequent visits and had repeat sweat tests. To determine the reproducibility of the sweat test, we repeated the test on 107 patients who served as controls and on 75 patients with cystic fibrosis. The patients' age range was three months to 40 years, the interval between tests was less than two months.
Results
A total of 143 patients were referred to our center for diagnostic or therapeutic reasons who had had sweat tests before our examination.
We repeated the sweat tests as outlined above. Fifteen patients had been diagnosed and treated for cystic fibrosis at nine different Cystic Fibrosis Centers recognized by the Cystic Fibrosis Foundation.
Our results in testing these 15 patients is given in Of great concern to us were the results obtained in local or small hospital laboratories.
One hundred and twenty-eight patients suspected of having CF were sweat tested in 84 separate institutions. Tables 2 through 5 present our results in sweat testing these patients. Eight patients were referred because of inadequate sweat samples, even after two separate attempts. Our results are shown in Table 2 . In six patients left and right forearms were sweated simultaneously. The values recorded in Table 2 give the mean values for Na, K, and Cl in six of the eight patients who had two tests simultaneously.
One patient was found to have cystic fibrosis. The mean sweat weight was 81 mg, which is less than in any of the other patients studied and may explain why the other laboratories were unable to perform the test. The amount of sweat in the patient with CF was slightly greater than in the remaining seven patients. When sweating is induced by pilocarpine iontophoresis there is no alteration in the weight of sweat produced by patients with CF and controls.
For 20 patients the sweat tests were negative before referral (Table 3) . Six patients had clinical manifestations of cystic fibrosis, and this diagnosis was confirmed by the sweat test. Fourteen patients did not have cystic fibrosis.
Fifty-eight patients had positive sweat tests before referral. Of these, 25 were confirmed, 28 were negative, and five were in the borderline zone in our laboratory (Table 4) . Of the five patients with borderline values, two have been followed sufficiently to eliminate the diagnosis of CF and the other three patients are still under observation and study.
Forty-two patients were referred who had borderline or doubtful sweat tests before referral, i.e., 35 of the 42 had negative sweat tests in our laboratory and did not have CF. Only one patient was noted to have CF and six patients had borderline values in our laboratory (Table 5) . Doubtful tests include a few patients who had both positive and negative results when tested more than once. Figure 1 shows the results of the repeat sweat tests with respect to sodium, potassium, and chloride. The correlation is highly satisfactory and indicates the constancy of the sweat One must also be alert to the variation possible in sweat electrolytes in the same patient at different times and under differing conditions. Variations may occur in relation to age and degree of malnutrition and after drug ingestion. Many factors that can influence the sweat test have been described (5). For practical purposes the effect of steroids, excess salt ingestion, or malnutrition, or the presence of edema will not seriously influence the result of the sweat test. Values may indeed change in the situations mentioned but a positive result will not become negative or vice versa. The difference between the CF range and the control range is so great that one would hardly expect errors on the above score, especially if the clinical condition of the patient is considered. One must always keep in mind that one sweat test result is not sufficient to confirm the diagnosis of CF. We strongly recommend two separate tests, preferably done not more than two months apart; repeat them again if conclusions about the diagnosis are suspect on clinical grounds. We have seen a few malnourished babies who had increased electrolyte concentrations, in the CF range, when first seen but whose values re- 
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Fig. 1. Quantitative pilocarpine iontophoresis
Comparison of results of repeat sweat tests in 75 patients with cystic fibrosis and in 107controls (non-cystic fibrosis). The second test was performed within two months after the first test. Age range, three monthsto 40 years. All vaiues in mmol/L turned to normal when the nutritional state improved. We have not had difficulty in the diagnosis in the case of babies with edema or those with adrenal insufficiency or diabetes insipidus. We have not seen a patient with fucosidosis and do not know if in this conditkkn the reported sweat abnormality is persistent.
It is the constancy of the abnormality that characterizes the sweat defect in cystic fibrosis. One must also recognize the individual sweat electrolyte characteristic of each person and the effect of heredity. For example, we have encountered some families in whom all members have consistently above-average values for sweat electrolytes and others in whom the values are consistently below average. Most individuals will repeatedly show the same electrolyte values for sweat, plus or minus one standard deviation. The analyses of finger-and toe-nail clippings represent the electrolytes absorbed into this tissue and nail analysis has been shown to yield reliable results (6) , although there are exceptions, including a few patients who have sweat values in the borderline zone. There is no sharp distinction or line that distinguishes a CF patient from normal, but a broad zone, which we consider to be between 45 and 65 mmol/L for, both sodium and chloride. Perhaps ito 2% of patients with CF will fall in this range.
The effect of age deserves comment. During the first two or three postnatal days sodium and chloride values may normally go as high as 75 to 80 mmolfL, returning to lower values on the third to fourth day. The potassium concentration is also higher at this early age than later in infancy and childhood. The values are rather stable throughout infancy and childhood, with a gradual increase occurring after 15 years. At 20 years the sodium and chloride values may be almost twice those in childhood. Adults with abnormally high sweat-electrolyte values-i.e., >70 mmolfL-merit the same diagnostic consideration as a child (7).
Patients with borderline results for sweat tests may at one time or another have sweat electrolyte values in the normal range and if only one sweat test is done they may be discharged and lost to followup. The diagnosis and management of these patients remain a difficult problem. Until we have a better direct test on the still-unknown metabolic defect, we must resort to indirect tests; one of the best is the sweat test combined with clinical judgement. One would not expect that 
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analysis of nail clippings would be any more helpful in these borderline cases than a reliable sweat test. We have always measured the sodium and chloride as well as potassium in each sweat analysis. Some physicians prefer to measure sodium, but most measure only chloride. There is greater security in measuring both elements, because one would expect an approximate chemical balance: if the chloride value is 96 mmol/L and the sodium value is 55 mmol/L, there is obviously an error, either in calculation, in the analysis, or from contamination. We also measure potassium, although in itself it has no diagnostic value. There is considerable overlapping of potassium values for CF and controls. However, potassium does contribute to the conductivity and osmolality of the sweat. One report (8) recommends measuring osmolality, and described equipment for this purpose, a procedure that has not been tested in this country. The value of the chloride plate test as a screening procedure is verified by the observations recorded in Tables 1-5 . Only one patient with cystic fibrosis had a 2+ reaction, all the other 47 patients with CF had a 3+ or 4+ reaction. No non-CF patient had a 2+ or 4+ reaction. Of the 11 patients with borderline values the plate test yielded 2+ or 3+ readings. We do not recommend the plate test as a definitive diagnostic test, but we do believe that it has a place as a rapid screening procedure.
